Latest stories on CNMD
CONMED Corporation 2026 Q2 - Results - Earnings Call Presentation
Seeking Alpha50 · neutralearnings
Conmed forecasts 2026 adjusted EPS of $4.48 to $4.60 while targeting 5% to 6% organic growth
Seeking Alpha67 · bullishearnings
CONMED Corporation (CNMD) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
CONMED Q2 Earnings Call Highlights
Yahoo Finance56 · neutralearnings
CONMED Corp (CNMD) files 8-K
SEC 8-K50 · neutralgeneral
CONMED Corporation Reports Second Quarter 2026 Financial Results; Updates Full Year 2026 Guidance
StockTitan56 · neutralearnings
CONMED Corporation to Participate in the Society of Robotic Surgery Annual Meeting
StockTitan56 · neutralproduct/pr
Why This Medical Technology Stock Is Up 10%
Barron's63 · neutralgeneral
CNMD Stock Hits Highest Level In Over Four Months – Why JPMorgan Believes Firm Would Be Highly Attractive To ‘Financial Acquirers’
Stocktwits News58 · neutralgeneral
Conmed Surges Within Striking Distance Of A Breakout On Buyout Rumors
Investors.com73 · bullishgeneral
CNMD Stock Surges As Much As 10% After-Hours On Reports Of Private Equity Takeover Interest
Stocktwits News67 · bullishm&a
Conmed jumps after report of takeover interest
Seeking Alpha67 · bullishm&a
CONMED Corporation to Report Second Quarter 2026 Financial Results on July 29, 2026 | CNMD Stock News
StockTitan50 · neutralearnings
Conmed Names John Gallagher as New Chief Financial Officer
TipRanks56 · neutralgeneral
CONMED names John Gallagher as chief financial officer
Seeking Alpha55 · neutralgeneral
CONMED Corp (CNMD) files 8-K
SEC 8-K50 · neutralgeneral
CONMED Corporation Appoints John E. Gallagher as Chief Financial Officer | CNMD Stock News
StockTitan56 · neutralgeneral
Conmed Retires Significant Portion of Convertible Senior Notes
TipRanks71 · bullishgeneral
CONMED Establishes New Term Loan to Refinance Notes
TipRanks58 · neutralgeneral